The analysis will enroll up to 25 individuals with metastatic cancer.

Aethlon receives acceptance to begin Hemopurifier research at Sarcoma Oncology Center Aethlon Medical, Inc. The analysis will enroll up to 25 individuals with metastatic cancer, including those with non-small cell lung tumor, prostate cancer, melanoma, head and neck cancer, and sarcoma.Tumor-secreted exosomes, which are not resolved by drug therapy, assist cancerous tumors in evading the immune response and are implicated in the survival, growth, and metastasis of cancer.But that move might not be enough, as the publisher Hindawi uncovered this past spring. Although Hindawi doesn’t let authors suggest reviewers because of their manuscripts, it made a decision to examine the peer-review records for manuscripts submitted in 2013 and 2014 for possible fraud. The peer-review procedure found in Hindawi’s journals depends generally on the expertise of its editorial board members and the guest editors of special issues, who are in charge of supervising the review of submitted manuscripts.5 Since the peer reviewers chosen by the guest editors weren’t subject to any sort of independent verification, editors themselves could undermine the procedure in quite similar way that authors or third-party agencies have done elsewhere: by creating fake reviewer identities and addresses that they submitted positive reviews endorsing publication.